This story first appeared in “Go West,” STAT’s weekly newsletter about West Coast life sciences, health care, and biotech. Sign up here to receive it in your inbox.
SAN FRANCISCO — There’s a high-stakes fight in California that could shape the way that academic research gets read and published far beyond the West Coast.
The battle is pitting the University of California system against Elsevier, the Netherlands-based publisher of academic journals. At issue is how open-access research gets paid for.
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.
Already have an account? Log in
To submit a correction request, please visit our Contact Us page.
